Results 151 to 160 of about 14,319 (252)
Ischemic Optic Neuropathy Decompression Trial (IONDT) [PDF]
Non-arteritic ischemic optic neuropathy (NAION), the most common cause of acute optic nerve disease in the elderly causes permanent and severe visual loss through decreased central visual acuity, peripheral visual field loss, or both. No proven treatment
Steven E. Feldon, MD, MBA
core
Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers
This schematic illustrates the hierarchical and interconnected nature of the primary molecular hallmarks of aging. The progression of aging is driven by a convergence of intrinsic molecular insults. Within the nucleus, genomic instability and telomere attrition trigger persistent DDR, accompanied by extensive epigenetic alterations.
Guowei Cai +10 more
wiley +1 more source
ABSTRACT Aims Diabetic retinopathy (DR) is linked to elevated risks of cerebrovascular diseases. Whether sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) reduce stroke risk in patients with type 2 diabetes (T2D) and DR remains uncertain. Materials and Methods We conducted a retrospective cohort study using the TriNetX Research Network.
Kuo‐En Chen +3 more
wiley +1 more source
Ischemic Optic Neuropathy: Analysis of Distribution and Etiologies in a Tertiary Care Center [PDF]
The spectrum of diseases responsible for ischemic optic neuropathies varies, yet the vast majority of these conditions stem from a relatively limited set of underlying causes.
Jimena Tatiana Hathaway; Madhura P. Shah; Drenushe Krasniqi; Joseph Rizzo III
core
Ischemic Optic Neuropathy Following Lumbar Fusion Surgery [PDF]
Nonarteritic ischemic optic neuropathy (na-ION) has been seen following cardiopulmonary bypass procedures, recurrent hemorrhage, therapeutic phlebotomy, bilateral radical neck dissection, intraoperative hypotension, hemodialysis and cardiac ...
David M. Katz, MD; Jonathan Trobe, MD; Wayne T. Cornblath, MD
core
ABSTRACT Aims To evaluate the effects of probiotics Bifidobacterium bifidum G9‐1 (BBG9‐1) on gastrointestinal symptoms in patients with Type 2 diabetes mellitus (T2DM) with diarrhoea or constipation. Materials and Methods In a 12‐week open‐label randomised controlled trial, 100 participants were randomized 1:1 to a control or BBG9‐1 group, with 12 mg ...
Genki Kobayashi +10 more
wiley +1 more source
In patients presenting to the emergency department with acute non‐traumatic headache, serum GFAP and neurofilament light chain were higher in serious secondary headache than in primary headache. GFAP showed stronger diagnostic performance and remained independently associated with serious secondary headache after adjustment for clinical risk factors ...
Sara‐Jessica Camerin +8 more
wiley +1 more source
An update on the landscape of collagen bioactive fragments
The remodeling of the extracellular matrix releases collagen bioactive fragments, which exert molecular functions and regulate numerous biological processes via several signaling pathways. Here, we summarize the latest findings describing the roles of major bioactive fragments from collagens I, IV, VI, and XVIII in various physiological and ...
Sylvie Ricard‐Blum, Julie Fradette
wiley +1 more source
A novel algorithm combining ABI and baPWV was developed to predict mortality and CVD risk in individuals with diabetes. This algorithm improved the accuracy of mortality and CVD risk assessment and was independent from the Framingham Risk Score. ABSTRACT Aims/Introduction People with diabetes exhibit early‐stage cardiovascular disease (CVD).
Erina Eto +6 more
wiley +1 more source
Abstract figure legend Overview of multiscale cardiac remodelling in type 2 diabetes and how to model and simulate these changes using a human‐based, multiscale computational framework. Cardiac remodelling in type 2 diabetes occurs at ionic channel, protein, cellular, tissue and whole‐organ level, affecting the electrophysiological function, mechanical
Ambre Bertrand +2 more
wiley +1 more source

